Editor profile
Managing Editor, Digital Health
Julian Sterling analyzes the evolution of global telemedicine platforms and health data management systems. He focuses on the digital transformation of patient care delivery.
julian.sterling@medtechdaily.orgThe U.S. FDA has selected Dexcom as the first participant in the TEMPO digital health device pilot. The AI-driven blood glucose management program will be granted exemption from certain premarket approval requirements, while collecting real-world data through Medicare.
The self-disinfecting medical device market is rapidly expanding at a compound annual growth rate of 14%, driven by rising hospital infection rates, a surge in surgical volumes, and increasing healthcare expenditure. This article analyzes market dynamics, key technology trends, and regional competitive landscape.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.
According to a sharing by Public Intelligence CEO Peter Julius on HIMSS TV, early trials of the social robot Hana-chan have shown that it can enhance patients' emotional well-being and help aggressive patients relax. This article analyzes the significance of this progress for the healthcare technology industry, the affected companies, and future trends.
Driven by personalized medicine, regulatory maturity, and declining costs of multi-laser systems, the global additive manufacturing market for medical devices is expected to grow at a compound annual growth rate of 15–20% from 2026 to 2035. Orthopedic implants and surgical guides account for 55–70% of revenue, and in-house 3D printing laboratories in hospitals are accelerating in adoption.
This week's healthcare technology industry highlights: Merck KGaA acquires Bio-Techne for $11.3 billion, expanding its life science tools business; Insilico Medicine and SK Biopharmaceuticals launch a $2.5 billion AI neuroimmune drug collaboration; Anthropic introduces the Claude Science platform for antibiotic design; Nipah virus and schistosomiasis vaccines achieve clinical progress.
The research team developed a clinical large language model named AI4Doctor, which significantly improved AI's decision-making ability in complex diagnosis scenarios by integrating electronic medical record data and doctor experience.
According to the latest PwC report, healthcare technology M&A transaction value reached $36.5 billion in the first half of 2026, continuing the ten-year high trend set in 2025, with strategic buyers focusing on high-growth areas and private equity capital actively entering the market.
According to the latest PwC report, the total value of medical technology M&A transactions in the first half of 2026 reached $36.5 billion, led by Boston Scientific's acquisition of Penumbra and Danaher's acquisition of Masimo, indicating that the industry's M&A momentum remains strong.
Deloitte's latest research shows that diagnostic manufacturers are shifting from traditional product suppliers to a B2B2C model, with AI, EHR workflow integration, and interoperability becoming key to the next stage of growth.